Provided by Tiger Trade Technology Pte. Ltd.

Edesa Biotech

0.9925
-0.0325-3.17%
Volume:100.94K
Turnover:103.97K
Market Cap:8.27M
PE:-0.87
High:1.06
Open:1.03
Low:0.9901
Close:1.03
52wk High:2.95
52wk Low:0.9400
Shares:8.33M
Float Shares:4.28M
Volume Ratio:0.51
T/O Rate:2.36%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.1438
EPS(LYR):-1.2658
ROE:-96.38%
ROA:-55.33%
PB:1.78
PE(LYR):-0.78

Loading ...

Edesa Biotech reports Q1 EPS (28c), consensus (45c)

TIPRANKS
·
Feb 14

Edesa Biotech Q1 EPS $(0.28) Beats $(0.45) Estimate

Benzinga
·
Feb 14

Edesa Biotech Inc. reports Q1 net loss of USD 2.2 million, up 38 percent

Reuters
·
Feb 14

Edesa Biotech Q1 Net Income USD -2.2 Million

THOMSON REUTERS
·
Feb 14

Press Release: Edesa Biotech Reports Fiscal 1st Quarter 2026 Results

Dow Jones
·
Feb 14

Skin drug developer Edesa Biotech's FY net loss widens to $7.2 mln

Reuters
·
Dec 13, 2025

Edesa Biotech Q4 EPS $(0.32) Misses $(0.27) Estimate

Benzinga
·
Dec 13, 2025

Edesa Biotech Inc. reports FY research and development expenses of USD 3.7 million, up 27%

Reuters
·
Dec 13, 2025

Edesa Biotech FY Operating Expenses USD 7.9 Million

THOMSON REUTERS
·
Dec 13, 2025

Press Release: Edesa Biotech Reports Fiscal Year 2025 Results

Dow Jones
·
Dec 13, 2025

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Dec 11, 2025

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Dec 08, 2025

Edesa Biotech (EDSA) Receives a Buy from H.C. Wainwright

TIPRANKS
·
Nov 04, 2025

Edesa Biotech Price Target Maintained With a $5.00/Share by HC Wainwright & Co.

Dow Jones
·
Nov 04, 2025

Edesa Biotech to Participate in Key Industry Conferences

TIPRANKS
·
Nov 01, 2025

Edesa Biotech Announces Upcoming Conference Schedule

GlobeNewswire
·
Nov 01, 2025

BRIEF-Edesa Biotech Reports Positive Results In Phase 3 Respiratory Study

Reuters
·
Oct 28, 2025

Edesa Biotech Reports Positive Phase 3 Results for ARDS Drug Paridiprubart

Reuters
·
Oct 28, 2025

Edesa Biotech Inc - Paridiprubart Shows 25% Reduction in Risk of Death

THOMSON REUTERS
·
Oct 28, 2025

Edesa Biotech Inc - Eb05 Well-Tolerated in Safety Population of Over 275 Subjects

THOMSON REUTERS
·
Oct 28, 2025